WVE (STOCKS)
Wave Life Sciences Ltd. Ordinary Shares
$7.190000
+0.010000 (+0.14%)
Prev close: $7.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul B. Bolno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,368.61M
- Employees
- 288
- P/E (TTM)
- -5.99
- P/B (TTM)
- 2.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.30 | $-0.27 | -0.0272 | -9.97% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.30 | -0.0187 | -6.21% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.29 | -0.0165 | -5.62% |
|
Mar 2025 (Q1)
|
$-0.29 | $-0.26 | -0.0265 | -10.06% |
Financial Statements
| Revenues | $42.73M |
| Benefits Costs and Expenses | $247.11M |
| Costs And Expenses | $247.11M |
| Nonoperating Income/Loss | $11.01M |
| Operating Expenses | $258.11M |
| Research and Development | $182.78M |
| Other Operating Expenses | $75.33M |
| Operating Income/Loss | -$215.38M |
| Income/Loss From Continuing Operations After Tax | -$204.38M |
| Income/Loss From Continuing Operations Before Tax | -$204.38M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$204.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$204.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$204.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.21 |
| Diluted Earnings Per Share | -$1.21 |
| Basic Average Shares | 168,649,795 |
| Diluted Average Shares | 168,649,795 |
| Assets | $638.50M |
| Current Assets | $614.81M |
| Prepaid Expenses | $8.40M |
| Other Current Assets | $606.42M |
| Noncurrent Assets | $23.69M |
| Fixed Assets | $7.41M |
| Other Non-current Assets | $16.28M |
| Liabilities | $112.27M |
| Current Liabilities | $95.07M |
| Accounts Payable | $15.70M |
| Wages | $18.08M |
| Other Current Liabilities | $61.29M |
| Noncurrent Liabilities | $17.20M |
| Equity | $518.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $518.36M |
| Temporary Equity | $7.87M |
| Temporary Equity Attributable To Parent | $7.87M |
| Liabilities And Equity | $638.50M |
| Net Cash Flow From Operating Activities | -$187.49M |
| Net Cash Flow From Operating Activities, Continuing | -$187.49M |
| Net Cash Flow From Investing Activities | -$718.00K |
| Net Cash Flow From Investing Activities, Continuing | -$718.00K |
| Net Cash Flow From Financing Activities | $488.24M |
| Net Cash Flow From Financing Activities, Continuing | $488.24M |
| Net Cash Flow | $300.02M |
| Net Cash Flow, Continuing | $300.02M |
| Comprehensive Income/Loss | -$204.37M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$204.37M |
| Other Comprehensive Income/Loss | $12.00K |